Cancer Research
- Prize For Cutting-Edge Laser Innovations
-
DITZINGEN, Germany, September 27 /PRNewswire/--- Call for international Berthold Leibinger Innovationspreis- November 30, 2007 is Deadline for Submissions ...
Article - Anna Ohlden - Sep 27 2007 - 4:03am
- Abbott's HUMIRA(R) (adalimumab) Honored With Prestigious Galen Prize For Innovation In Patient Care
-
ABBOTT PARK, Illinois, September 27 /PRNewswire/--- Prix Galien USA Names HUMIRA Best Biotechnology Product Abbott (NYSE: ABT), a leader in the treatment of autoimmune diseases, has received the 2007 Galen Prize for Best Biotechnology Product for HUMIRA ( ...
Article - Anna Ohlden - Sep 27 2007 - 1:05pm
- ImmunoVaccine Technologies Inc. Nears Phase I Clinical Trials With Completion Of Scientific Advisory Board
-
HALIFAX, England, September 27 /PRNewswire/-- ImmunoVaccine Technologies Inc. (IVT) finalizes an important step in its progress with the last appointment to its scientific advisory board (SAB), international oncology expert, Dr. Neil Berinstein. ...
Article - Anna Ohlden - Sep 27 2007 - 1:55pm
- Get Testicular Cancer, Get A Divorce
-
A new study by Norwegian researchers investigating how cancer influences divorce found that most types of cancer resulted in a slight decrease in the divorce rate in the first few years following the diagnosis- except cervical or testicular cancer. The som ...
Article - News Staff - Sep 27 2007 - 6:16pm
- Alcohol And Breast Cancer: It's As Bad As Smoking
-
It doesn't matter if it's wine or beer, the increased breast cancer risk from drinking three or more alcoholic drinks a day is similar to the increased breast cancer risk from smoking a packet of cigarettes or more a day. Dr Arthur Klatsky said: ...
Article - News Staff - Sep 28 2007 - 11:45am
- Oncolytics Biotech Inc. Reports Positive Interim Results Of U.K. Phase Ia/Ib Combination REOLYSIN(R) And Radiation Clinical Tria
-
CALGARY, Canada, September 28 /PRNewswire/-- Oncolytics Biotech Inc. ("Oncolytics") (TSX:ONC, NASDAQ:ONCY) today announced that an oral presentation covering interim results from a U.K. Phase Ia/Ib combination REOLYSIN(R) and radiation clinical ...
Article - Anna Ohlden - Sep 28 2007 - 3:04pm
- The TGF-Beta Link Between Cholesterol And Heart Disease
-
Cholesterol contributes to atherosclerosis – a condition that greatly increases the risk of heart attack and stroke – by suppressing the activity of a key protein that protects the heart and blood vessels, researchers at the Saint Louis University School o ...
Article - News Staff - Sep 29 2007 - 6:12am
- MicroRNA Not Just Cancer- It May Also Help HIV Hide
-
Tiny pieces of genetic material called microRNA (miRNA), better known for its roles in cancer, could be a key to unlocking the secrets of how HIV, the AIDS virus, evades detection, hiding in the immune system. Researchers at Jefferson Medical College in Ph ...
Article - News Staff - Sep 30 2007 - 4:20pm
- EphB2 And EphB3 Help Prevent Spread Of Colon Cancer
-
The first step in the development of colon cancer is the formation of benign tumours, called adenomas, in the intestine. Over time, these tumours may progress to produce colon cancer if they undergo a series of mutations and genetic alterations. Researcher ...
Article - News Staff - Sep 30 2007 - 4:22pm
- Biodegradable Polymers For Safer Gene Therapy
-
In work that could lead to safe and effective techniques for gene therapy, MIT researchers have found a way to fine-tune the ability of biodegradable polymers to deliver genes. Gene therapy, which involves inserting new genes into patients' cells to f ...
Article - News Staff - Oct 1 2007 - 12:17am